{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:07:27Z","timestamp":1791983247232,"version":"4.4.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T00:00:00Z","timestamp":1477008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,10,21]],"date-time":"2016-10-21T00:00:00Z","timestamp":1477008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","award":["D43 TW009359"],"award-info":[{"award-number":["D43 TW009359"]}],"id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["UID 76684"],"award-info":[{"award-number":["UID 76684"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12985-016-0636-x","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T23:06:44Z","timestamp":1477004804000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Serologic and genotypic characterization of hepatitis B virus in HIV-1 infected patients from South West and Littoral Regions of Cameroon"],"prefix":"10.1186","volume":"13","author":[{"given":"Tshifhiwa","family":"Magoro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Gachara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lufuno","family":"Mavhandu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmaculate","family":"Lum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen K.","family":"Kimbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland N.","family":"Ndip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Bessong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,10,21]]},"reference":[{"issue":"5 Suppl","key":"636_CR1","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1002\/hep.22881","volume":"49","author":"TJ Liang","year":"2009","unstructured":"Liang TJ. Hepatitis B: the virus and disease. Hepatology. 2009;49(5 Suppl):S13\u201321.","journal-title":"Hepatology"},{"issue":"Pt 4","key":"636_CR2","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1099\/0022-1317-82-4-693","volume":"82","author":"P Simmonds","year":"2001","unstructured":"Simmonds P. The origin and evolution of hepatitis viruses in humans. J Gen Virol. 2001;82(Pt 4):693\u2013712.","journal-title":"J Gen Virol"},{"issue":"1","key":"636_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jcv.2013.06.028","volume":"58","author":"JC Forbi","year":"2013","unstructured":"Forbi JC, Ben-Ayed Y, Xia GL, Vaughan G, Drobeniuc J, Switzer WM, Khudyakov YE. Disparate distribution of hepatitis B virus genotypes in four sub-Saharan African countries. J Clin Virol. 2013;58(1):59\u201366.","journal-title":"J Clin Virol"},{"issue":"Suppl 3","key":"636_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3851\/IMP1622","volume":"15","author":"F Bonino","year":"2010","unstructured":"Bonino F, Piratvisuth T, Brunetto MR, Liaw YF. Diagnostic markers of chronic hepatitis B infection and disease. Antivir Ther. 2010;15 Suppl 3:35\u201344.","journal-title":"Antivir Ther"},{"issue":"1","key":"636_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s11894-011-0233-5","volume":"14","author":"S Tanwar","year":"2012","unstructured":"Tanwar S, Dusheiko G. Is there any value to hepatitis B virus genotype analysis? Curr Gastroenterol Rep. 2012;14(1):37\u201346.","journal-title":"Curr Gastroenterol Rep"},{"key":"636_CR6","doi-asserted-by":"publisher","unstructured":"Hernandez S, Venegas M, Brahm J, Villanueva RA. Full-genome sequence of a hepatitis B virus genotype f1b clone from a chronically infected Chilean patient. Genome Announcements. 2014;2(5). doi:\n                    10.1128\/genomeA.01075-14\n                    \n                  .","DOI":"10.1128\/genomeA.01075-14"},{"issue":"5","key":"636_CR7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1365-2893.2005.00624.x","volume":"12","author":"A Kramvis","year":"2005","unstructured":"Kramvis A, Kew MC. Relationship of genotypes of hepatitis B virus to mutations, disease progression and response to antiviral therapy. J Viral Hepat. 2005;12(5):456\u201364.","journal-title":"J Viral Hepat"},{"issue":"2","key":"636_CR8","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/s12072-008-9112-z","volume":"3","author":"BJ McMahon","year":"2009","unstructured":"McMahon BJ. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int. 2009;3(2):334\u201342.","journal-title":"Hepatol Int"},{"issue":"1 Suppl","key":"636_CR9","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/j.jhep.2005.11.004","volume":"44","author":"MJ Alter","year":"2006","unstructured":"Alter MJ. Epidemiology of viral hepatitis and HIV co-infection. J Hepatol. 2006;44(1 Suppl):S6\u20139.","journal-title":"J Hepatol"},{"issue":"38","key":"636_CR10","doi-asserted-by":"publisher","first-page":"35435","DOI":"10.1074\/jbc.M103020200","volume":"276","author":"M Gomez-Gonzalo","year":"2001","unstructured":"Gomez-Gonzalo M, Carretero M, Rullas J, Lara-Pezzi E, Aramburu J, Berkhout B, Alcami J, Lopez-Cabrera M. The hepatitis B virus X protein induces HIV-1 replication and transcription in synergy with T-cell activation signals: functional roles of NF-kappaB\/NF-AT and SP1-binding sites in the HIV-1 long terminal repeat promoter. J Biol Chem. 2001;276(38):35435\u201343.","journal-title":"J Biol Chem"},{"issue":"1 Suppl","key":"636_CR11","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1016\/j.jhep.2005.11.007","volume":"44","author":"JK Rockstroh","year":"2006","unstructured":"Rockstroh JK. Influence of viral hepatitis on HIV infection. J Hepatol. 2006;44(1 Suppl):S25\u20137.","journal-title":"J Hepatol"},{"issue":"13","key":"636_CR12","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1517\/14656566.7.13.1835","volume":"7","author":"C Hache","year":"2006","unstructured":"Hache C, Villeneuve JP. Lamivudine treatment in patients with chronic hepatitis B and cirrhosis. Expert Opin Pharmacother. 2006;7(13):1835\u201343.","journal-title":"Expert Opin Pharmacother"},{"issue":"15","key":"636_CR13","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1056\/NEJMoa033364","volume":"351","author":"YF Liaw","year":"2004","unstructured":"Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, Tanwandee T, Tao QM, Shue K, Keene ON, et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med. 2004;351(15):1521\u201331.","journal-title":"N Engl J Med"},{"key":"636_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1155\/2012\/458372","volume":"2012","author":"F Fouelifack Ymele","year":"2012","unstructured":"Fouelifack Ymele F, Keugoung B, Fouedjio JH, Kouam N, Mendibi S, Dongtsa Mabou J. High Rates of Hepatitis B and C and HIV Infections among Blood Donors in Cameroon: A Proposed Blood Screening Algorithm for Blood Donors in Resource-Limited Settings. J Blood Transfusion. 2012;2012:7.","journal-title":"J Blood Transfusion"},{"issue":"9","key":"636_CR15","doi-asserted-by":"publisher","first-page":"e0137375","DOI":"10.1371\/journal.pone.0137375","volume":"10","author":"JJ Noubiap","year":"2015","unstructured":"Noubiap JJ, Aka PV, Nanfack AJ, Agyingi LA, Ngai JN, Nyambi PN. Hepatitis B and C Co-Infections in Some HIV-Positive Populations in Cameroon, West Central Africa: Analysis of Samples Collected Over More Than a Decade. PLoS ONE. 2015;10(9):e0137375.","journal-title":"PLoS ONE"},{"issue":"2","key":"636_CR16","doi-asserted-by":"publisher","first-page":"165","DOI":"10.2174\/1570162X13666150930114742","volume":"14","author":"S Romina","year":"2016","unstructured":"Romina S, Joseph F, Laura C, Maria-Mercedes S, Aubin N, Samuel Martin S, Mathurin K, Valeria C, Judith T, Loredana S, et al. High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians. Curr HIV Res. 2016;14(2):165\u201371.","journal-title":"Curr HIV Res"},{"issue":"8","key":"636_CR17","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/j.1365-2036.2005.02653.x","volume":"22","author":"A Marrone","year":"2005","unstructured":"Marrone A, Zampino R, Karayannis P, Cirillo G, Cesaro G, Guerrera B, Ricciotti R, del Giudice EM, Utili R, Adinolfi LE, et al. Clinical reactivation during lamivudine treatment correlates with mutations in the precore\/core promoter and polymerase regions of hepatitis B virus in patients with anti-hepatitis B e-positive chronic hepatitis. Aliment Pharmacol Ther. 2005;22(8):707\u201314.","journal-title":"Aliment Pharmacol Ther"},{"issue":"12","key":"636_CR18","doi-asserted-by":"publisher","first-page":"2725","DOI":"10.1093\/molbev\/mst197","volume":"30","author":"K Tamura","year":"2013","unstructured":"Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. MEGA6: Molecular Evolutionary Genetics Analysis version 6.0. Mol Biol Evol. 2013;30(12):2725\u20139.","journal-title":"Mol Biol Evol"},{"issue":"2","key":"636_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF01731581","volume":"16","author":"M Kimura","year":"1980","unstructured":"Kimura M. A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences. J Mol Evol. 1980;16(2):111\u201320.","journal-title":"J Mol Evol"},{"key":"636_CR20","unstructured":"Geno2pheno hbv [\n                    http:\/\/hbv.geno2pheno.org\/index.php\n                    \n                  ]. Accessed 18 May 2016."},{"key":"636_CR21","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/1756-0500-7-394","volume":"7","author":"AAB Frambo","year":"2014","unstructured":"Frambo AAB, Atashili J, Fon PN, Ndumbe PM. Prevalence of HBsAg and knowledge about hepatitis B in pregnancy in the Buea Health District, Cameroon: a cross-sectional study. BMC Res Notes. 2014;7:394.","journal-title":"BMC Res Notes"},{"key":"636_CR22","doi-asserted-by":"crossref","unstructured":"Ducancelle A, Abgueguen P, Birguel J, Mansour W, Pivert A, Guillou-Guillemette H, Sobnangou J-J, Rameau A, Huraux J-M, Lunel-Fabiani F. High endemicity and low molecular diversity of hepatitis B virus infections in pregnant women in a rural district of North Cameroon. PLoS ONE. 2013;8.","DOI":"10.1371\/journal.pone.0080346"},{"issue":"Suppl 3","key":"636_CR23","doi-asserted-by":"publisher","first-page":"S274","DOI":"10.1097\/QAI.0000000000000496","volume":"68","author":"L Stabinski","year":"2015","unstructured":"Stabinski L, O\u2019Connor S, Barnhart M, Kahn RJ, Hamm TE. Prevalence of HIV and hepatitis B virus co-infection in sub-Saharan Africa and the potential impact and program feasibility of hepatitis B surface antigen screening in resource-limited settings. J Acquir Immune Defic Syndr. 2015;68 Suppl 3:S274\u201385.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"636_CR24","doi-asserted-by":"publisher","first-page":"e358","DOI":"10.1016\/S2214-109X(15)00056-X","volume":"3","author":"MI Andersson","year":"2015","unstructured":"Andersson MI, Rajbhandari R, Kew MC, Vento S, Preiser W, Hoepelman AIM, Theron G, Cotton M, Cohn J, Glebe D, et al. Mother-to-child transmission of hepatitis B virus in sub-Saharan Africa: time to act. Lancet Global Health. 2015;3(7):e358\u20139.","journal-title":"Lancet Global Health"},{"key":"636_CR25","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1743-422X-2-82","volume":"2","author":"SK Sharma","year":"2005","unstructured":"Sharma SK, Saini N, Chwla Y. Hepatitis B Virus: Inactive carriers. Virol J. 2005;2:82.","journal-title":"Virol J"},{"issue":"2","key":"636_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/jmv.24326","volume":"88","author":"Q Wang","year":"2016","unstructured":"Wang Q, Luan W, Warren L, Fiel MI, Blank S, Kadri H, Tuvin D, Hiotis SP. Serum hepatitis B surface antigen correlates with tissue covalently closed circular DNA in patients with hepatitis B-associated hepatocellular carcinoma. J Med Virol. 2016;88(2):244\u201351.","journal-title":"J Med Virol"},{"issue":"2","key":"636_CR27","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3851\/IMP1911","volume":"17","author":"C Kouanfack","year":"2012","unstructured":"Kouanfack C, Aghokeng AF, Mondain AM, Bourgeois A, Kenfack A, Mpoudi-Ngole E, Ducos J, Delaporte E, Laurent C. Lamivudine-resistant HBV infection in HIV-positive patients receiving antiretroviral therapy in a public routine clinic in Cameroon. Antivir Ther. 2012;17(2):321\u20136.","journal-title":"Antivir Ther"},{"issue":"1","key":"636_CR28","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1469-0691.2010.03205.x","volume":"17","author":"JM Hubschen","year":"2011","unstructured":"Hubschen JM, Mbah PO, Forbi JC, Otegbayo JA, Olinger CM, Charpentier E, Muller CP. Detection of a new subgenotype of hepatitis B virus genotype A in Cameroon but not in neighbouring Nigeria. Clin Microbiol Infect. 2011;17(1):88\u201394.","journal-title":"Clin Microbiol Infect"},{"issue":"s1","key":"636_CR29","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1111\/j.1872-034X.2007.00098.x","volume":"37","author":"A Kramvis","year":"2007","unstructured":"Kramvis A, Kew MC. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypes. Hepatol Res. 2007;37(s1):S9\u2013S19.","journal-title":"Hepatol Res"},{"issue":"1","key":"636_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-016-1916-7","volume":"9","author":"KA Tufon","year":"2016","unstructured":"Tufon KA, Meriki HD, Anong DN, Mbunkah HA, Nkuo-Akenji T. Genetic diversity, viraemic and aminotransferases levels in chronic infected hepatitis B patients from Cameroon. BMC Res Notes. 2016;9(1):1\u20137.","journal-title":"BMC Res Notes"},{"key":"636_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ijid.2014.07.002","volume":"29","author":"M Yousif","year":"2014","unstructured":"Yousif M, Mudawi H, Hussein W, Mukhtar M, Nemeri O, Glebe D, Kramvis A. Genotyping and virological characteristics of hepatitis B virus in HIV-infected individuals in Sudan. Int J Infect Dis. 2014;29:125\u201332.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"636_CR32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1002\/jmv.23183","volume":"84","author":"Q Ma","year":"2012","unstructured":"Ma Q, Wang Y. Comprehensive analysis of the prevalence of hepatitis B virus escape mutations in the major hydrophilic region of surface antigen. J Med Virol. 2012;84(2):198\u2013206.","journal-title":"J Med Virol"},{"issue":"Suppl 1","key":"636_CR33","doi-asserted-by":"publisher","first-page":"S66","DOI":"10.1002\/jmv.20611","volume":"78","author":"H Scheiblauer","year":"2006","unstructured":"Scheiblauer H, Soboll H, Nick S. Evaluation of 17 CE-marked HBsAg assays with respect to clinical sensitivity, analytical sensitivity, and hepatitis B virus mutant detection. J Med Virol. 2006;78 Suppl 1:S66\u201370.","journal-title":"J Med Virol"},{"issue":"24","key":"636_CR34","doi-asserted-by":"publisher","first-page":"7653","DOI":"10.3748\/wjg.v20.i24.7653","volume":"20","author":"I Lazarevic","year":"2014","unstructured":"Lazarevic I. Clinical implications of hepatitis B virus mutations: Recent advances. World J Gastroenterol. 2014;20(24):7653\u201364.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"636_CR35","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jhep.2006.01.001","volume":"44","author":"T Shaw","year":"2006","unstructured":"Shaw T, Bartholomeusz A, Locarnini S. HBV drug resistance: mechanisms, detection and interpretation. J Hepatol. 2006;44(3):593\u2013606.","journal-title":"J Hepatol"},{"issue":"21","key":"636_CR36","doi-asserted-by":"publisher","first-page":"11833","DOI":"10.1128\/JVI.77.21.11833-11841.2003","volume":"77","author":"WE Delaney","year":"2003","unstructured":"Delaney WE, Yang H, Westland CE, Das K, Arnold E, Gibbs CS, Miller MD, Xiong S. The hepatitis B virus polymerase mutation rtV173L is selected during lamivudine therapy and enhances viral replication in vitro. J Virol. 2003;77(21):11833\u201341.","journal-title":"J Virol"},{"issue":"2","key":"636_CR37","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1093\/jac\/dki457","volume":"57","author":"C Alvarado-Esquivel","year":"2006","unstructured":"Alvarado-Esquivel C, de la Ascension C-GM, Conde-Gonzalez CJ, Juarez-Figueroa L, Ruiz-Maya L, Aguilar-Benavides S, Torres-Valenzuela A, Sablon E. Genotypic resistance to lamivudine among hepatitis B virus isolates in Mexico. J Antimicrob Chemother. 2006;57(2):221\u20133.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"636_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0213-005X(04)73051-7","volume":"22","author":"P Leon","year":"2004","unstructured":"Leon P, Pozo F, Echevarria JM. Detection of hepatitis B virus variants resistant to lamivudine and famciclovir among randomly selected chronic carriers from Spain. Enferm Infecc Microbiol Clin. 2004;22(3):133\u20137.","journal-title":"Enferm Infecc Microbiol Clin"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-016-0636-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-016-0636-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-016-0636-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T06:04:06Z","timestamp":1589522646000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-016-0636-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10,21]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["636"],"URL":"https:\/\/doi.org\/10.1186\/s12985-016-0636-x","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,10,21]]},"assertion":[{"value":"29 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"178"}}